Literature DB >> 14645453

Effects of interactions between interleukin-1 beta and leptin on cat intestinal vagal mechanoreceptors.

Stéphanie Gaigé1, Einate Abou, Anne Abysique, Michel Bouvier.   

Abstract

In a previous study, we established that leptin acts on chemosensitive intestinal vagal mechanoreceptors and that its excitatory effects are blocked by the endogenous interleukin-1beta receptor antagonist (Il-1ra). To determine how interleukin-1beta (Il-1beta) is involved in the action of leptin, we studied the effects of this drug on the single vagal afferent activities of intestinal mechanoreceptors in anaesthetized cats. For this purpose, the activity of 34 intestinal vagal mechanoreceptors was recorded via glass microelectrodes implanted in the nodose ganglion. Il-1beta (1 microg) administered into the artery irrigating the upper part of the intestine activated both the 16 leptin-activated units (type 1 units; P < 0.01) and the 12 leptin-inhibited units (type 2 units; P < 0.001), but had no effect on the six leptin-insensitive units. Cholecystokinin (CCK, 10 microg) induced an activatory response only in the two types of Il-1beta-sensitive units. When Il-1beta was administered after CCK, its excitatory effects on type 1 units were enhanced, whereas the excitatory effects on type 2 units were abolished. Pre-treatment with Il-1ra (250 microg) blocked all the effects of Il-1beta and the excitatory effects of leptin on type 1 units, whereas it enhanced the inhibitory effects of leptin on type 2 units. It can therefore be concluded that (i) leptin acts on intestinal vagal mechanoreceptors via Il-1beta in the case of the type 1 units and independently of Il-1beta in the case of the type 2 units, and (ii) type 1 and type 2 units belong to two different populations of vagal afferents that transmit different information about ingestion or inflammation to the CNS, depending on the chemical environment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14645453      PMCID: PMC1664812          DOI: 10.1113/jphysiol.2003.054379

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  52 in total

Review 1.  Neurochemistry of the nodose ganglion.

Authors:  H Zhuo; H Ichikawa; C J Helke
Journal:  Prog Neurobiol       Date:  1997-06       Impact factor: 11.685

2.  Effects of area postrema lesion and abdominal vagotomy on interleukin-1 beta-induced norepinephrine release in the hypothalamic paraventricular nucleus region in the rat.

Authors:  Y Ishizuka; Y Ishida; T Kunitake; K Kato; T Hanamori; Y Mitsuyama; H Kannan
Journal:  Neurosci Lett       Date:  1997-02-14       Impact factor: 3.046

3.  Expression and regulation of leptin receptor proteins in afferent and efferent neurons of the vagus nerve.

Authors:  M Buyse; M L Ovesjö; H Goïot; S Guilmeau; G Péranzi; L Moizo; F Walker; M J Lewin; B Meister; A Bado
Journal:  Eur J Neurosci       Date:  2001-07       Impact factor: 3.386

4.  The afferent discharges from sensors for interleukin 1 beta in the hepatoportal system in the anesthetized rat.

Authors:  A Niijima
Journal:  J Auton Nerv Syst       Date:  1996-12-14

Review 5.  Neural-immune gut-brain communication in the anorexia of disease.

Authors:  Gary J Schwartz
Journal:  Nutrition       Date:  2002-06       Impact factor: 4.008

6.  Interleukin-1 increases activity of the gastric vagal afferent nerve partly via stimulation of type A CCK receptor in anesthetized rats.

Authors:  M Kurosawa; K Uvnäs-Moberg; K Miyasaka; T Lundeberg
Journal:  J Auton Nerv Syst       Date:  1997-01-12

7.  Lipopolysaccharide and interleukin-1 depress food-motivated behavior in mice by a vagal-mediated mechanism.

Authors:  J L Bret-Dibat; R M Bluthé; S Kent; K W Kelley; R Dantzer
Journal:  Brain Behav Immun       Date:  1995-09       Impact factor: 7.217

8.  Interleukin-1 beta induced corticosterone elevation and hypothalamic NE depletion is vagally mediated.

Authors:  M Fleshner; L E Goehler; J Hermann; J K Relton; S F Maier; L R Watkins
Journal:  Brain Res Bull       Date:  1995       Impact factor: 4.077

Review 9.  Cholecystokinin receptors.

Authors:  S A Wank
Journal:  Am J Physiol       Date:  1995-11

10.  Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia.

Authors:  P Sarraf; R C Frederich; E M Turner; G Ma; N T Jaskowiak; D J Rivet; J S Flier; B B Lowell; D L Fraker; H R Alexander
Journal:  J Exp Med       Date:  1997-01-06       Impact factor: 14.307

View more
  7 in total

Review 1.  Regulation of energy balance by a gut-brain axis and involvement of the gut microbiota.

Authors:  Paige V Bauer; Sophie C Hamr; Frank A Duca
Journal:  Cell Mol Life Sci       Date:  2015-11-05       Impact factor: 9.261

Review 2.  The vagus nerve and the inflammatory reflex--linking immunity and metabolism.

Authors:  Valentin A Pavlov; Kevin J Tracey
Journal:  Nat Rev Endocrinol       Date:  2012-12       Impact factor: 43.330

3.  Gastrointestinal hormones and the dialogue between gut and brain.

Authors:  Graham J Dockray
Journal:  J Physiol       Date:  2014-02-24       Impact factor: 5.182

4.  Neurobiology of inflammation-associated anorexia.

Authors:  Laurent Gautron; Sophie Layé
Journal:  Front Neurosci       Date:  2010-01-08       Impact factor: 4.677

5.  Expression of leptin receptor gene in developing and adult zebrafish.

Authors:  Qin Liu; Yun Chen; Donald Copeland; Hope Ball; Robert J Duff; Briana Rockich; Richard L Londraville
Journal:  Gen Comp Endocrinol       Date:  2009-11-24       Impact factor: 2.822

Review 6.  Sensory and sympathetic nervous system control of white adipose tissue lipolysis.

Authors:  Timothy J Bartness; Y B Shrestha; C H Vaughan; G J Schwartz; C K Song
Journal:  Mol Cell Endocrinol       Date:  2009-09-10       Impact factor: 4.102

7.  Gastric expression of plasminogen activator inhibitor (PAI)-1 is associated with hyperphagia and obesity in mice.

Authors:  Susan Kenny; Joanne Gamble; Suzanne Lyons; Nikolina Vlatkovic; Rod Dimaline; Andrea Varro; Graham J Dockray
Journal:  Endocrinology       Date:  2012-12-18       Impact factor: 4.736

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.